BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19273283)

  • 1. c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy.
    Matsushita K; Tomonaga T; Kajiwara T; Shimada H; Itoga S; Hiwasa T; Kubo S; Ochiai T; Matsubara H; Nomura F
    Front Biosci (Landmark Ed); 2009 Jan; 14(9):3401-8. PubMed ID: 19273283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.
    Matsushita K; Tomonaga T; Shimada H; Shioya A; Higashi M; Matsubara H; Harigaya K; Nomura F; Libutti D; Levens D; Ochiai T
    Cancer Res; 2006 Feb; 66(3):1409-17. PubMed ID: 16452196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.
    Matsushita K; Shimada H; Ueda Y; Inoue M; Hasegawa M; Tomonaga T; Matsubara H; Nomura F
    World J Gastroenterol; 2014 Apr; 20(15):4316-28. PubMed ID: 24764668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
    Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
    Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
    Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
    Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.
    Rahmutulla B; Matsushita K; Satoh M; Seimiya M; Tsuchida S; Kubo S; Shimada H; Ohtsuka M; Miyazaki M; Nomura F
    Oncotarget; 2014 May; 5(9):2404-17. PubMed ID: 24811221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FBP interacting repressor targets TFIIH to inhibit activated transcription.
    Liu J; He L; Collins I; Ge H; Libutti D; Li J; Egly JM; Levens D
    Mol Cell; 2000 Feb; 5(2):331-41. PubMed ID: 10882074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
    Liu J; Kouzine F; Nie Z; Chung HJ; Elisha-Feil Z; Weber A; Zhao K; Levens D
    EMBO J; 2006 May; 25(10):2119-30. PubMed ID: 16628215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.
    Kajiwara T; Matsushita K; Itoga S; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Habara Y; Matsuo M; Nomura F
    Cancer Sci; 2013 Feb; 104(2):149-56. PubMed ID: 23113893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of alternative splicing form of c-myc suppressor FUSE-binding protein-interacting repressor for cancer detection and treatment].
    Matsushita K; Kajiwara T; Itoga S; Satoh M; Sogawa K; Umemura H; Sawai S; Nishimura M; Tamura M; Tanaka N; Shimada H; Tomonaga T; Nomura F
    Rinsho Byori; 2009 Dec; 57(12):1151-8. PubMed ID: 20077813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alternative Splicing Detection as Biomarker Candidates for Cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
    Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
    Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.
    Crichlow GV; Zhou H; Hsiao HH; Frederick KB; Debrosse M; Yang Y; Folta-Stogniew EJ; Chung HJ; Fan C; De la Cruz EM; Levens D; Lolis E; Braddock D
    EMBO J; 2008 Jan; 27(1):277-89. PubMed ID: 18059478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative characterization of the interactions among c-myc transcriptional regulators FUSE, FBP, and FIR.
    Hsiao HH; Nath A; Lin CY; Folta-Stogniew EJ; Rhoades E; Braddock DT
    Biochemistry; 2010 Jun; 49(22):4620-34. PubMed ID: 20420426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
    Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
    Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.
    Kitamura A; Matsushita K; Takiguchi Y; Shimada H; Tada Y; Yamanaka M; Hiroshima K; Tagawa M; Tomonaga T; Matsubara H; Inoue M; Hasegawa M; Sato Y; Levens D; Tatsumi K; Nomura F
    Cancer Sci; 2011 Jul; 102(7):1366-73. PubMed ID: 21435101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis.
    Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Ueda Y; Shimada H; Matsushita K; Shiotani A
    PLoS One; 2015; 10(1):e0116279. PubMed ID: 25569246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of FIR-mediated c-myc transcriptional control.
    Cukier CD; Hollingworth D; Martin SR; Kelly G; Díaz-Moreno I; Ramos A
    Nat Struct Mol Biol; 2010 Sep; 17(9):1058-64. PubMed ID: 20711187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum.
    Liu J; Akoulitchev S; Weber A; Ge H; Chuikov S; Libutti D; Wang XW; Conaway JW; Harris CC; Conaway RC; Reinberg D; Levens D
    Cell; 2001 Feb; 104(3):353-63. PubMed ID: 11239393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer.
    Kitamura K; Hoshino T; Okabe A; Fukuyo M; Rahmutulla B; Tanaka N; Kobayashi S; Tanaka T; Shida T; Ueda M; Minamoto T; Matsubara H; Kaneda A; Ishii H; Matsushita K
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.